Scientists discuss in 'Role of endoscopic ultrasound-guided fine-needle aspiration with flow cytometry to diagnose lymphoma: a single center experience' new findings in lymphoma. The use of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) flow cytometry (FC) for the diagnosis of suspected lymphoma remains controversial.
ARIAD Pharmaceuticals, Inc. announced the completion of patient enrollment in its pivotal, Phase 3 clinical trial of oral ridaforolimus, its investigational mTOR inhibitor, in patients with metastatic soft-tissue and bone sarcomas. The Company believes that this international study is the largest clinical trial to be conducted in patients with sarcomas. It was initiated in September, 2007 and took just over two years to fully accrue.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant.
Since its description in 1966 by Donald Gleason, the Gleason grading has remained a cornerstone in the diagnosis and management of prostate cancer. With widespread use of the prostate specific antigen screening, the diagnosis and management patterns of prostate cancers have dramatically changed, investigators in the United States report.
In this recent study, researchers in the United States conducted a study To investigate the feasibility of transoral robotic surgery as a method of surgical treatment of oropharyngeal squamous cell carcinoma. Prospective case study.
Results from a phase III pivotal study sub- analyses reported in European Urology show that prostate cancer patients who received Firmagon (degarelix) in the study have a statistically significant greater probability of PSA (prostate- specific-antigen) recurrence-free survival compared with those taking leuprolide (P=0.05).
Today, the United States Congress approved an additional $15 million in research funding for lung cancer as part of the fiscal year 2010 Department of Defense (DOD) Appropriations package. This brings the total to $35 million that Congress has appropriated to date for the new program since it was launched in October of last year. The bill will now be sent to the President for signature.
Pro-Pharmaceuticals, Inc. announced that the Brussels Branch of the Ludwig Institute of Cancer Research is testing the ability of DAVANAT to stop Galectin-3 from blocking the immune system's action on cancer cells. Peer reviewed studies have demonstrated that Galectin- 1 and Galectin-3 induce apoptosis (cell death) in immune system T cells (Galectins, Chapter 7, Wiley, 2008).
Dear Dr. Gott: A 38-year-old female relative was recently diagnosed with an internal melanoma. She had a persistent cough, which led to a chest X-ray and then an upper-body scan. Something showed on the lungs, and then a mass was found on the liver. Any information you can provide would be greatly appreciated.
New research, 'Antioxidant activity of mangostin in cell-free system and its effect on K562 leukemia cell line in photodynamic therapy,' is the subject of a report. According to recent research from People's Republic of China, Mangostin (MAG), a kind of xanthone widely used in diet and medicine, has antioxidant, anti- inflammatory, antimicrobial, and anticancer activities.
